Crowston Jonathan G, Lindsey James D, Morris Christy A, Wheeler Larry, Medeiros Felipe A, Weinreb Robert N
Hamilton Glaucoma Center and Department of Ophthalmology, University of California San Diego, La Jolla, California 92093-0946, USA.
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4571-7. doi: 10.1167/iovs.05-0723.
To determine the effect of bimatoprost on intraocular pressure in the prostaglandin FP receptor knockout mouse.
The IOP response to a single 1.2-microg (4 microL) dose of bimatoprost was measured in the treated and untreated fellow eyes of homozygote (FP+/+, n = 9) and heterozygote (FP+/-, n = 10) FP-knockout mice, as well as in wild-type C57BL/6 mice (FP+/+, n = 20). Serial IOP measurements were also performed after topical bimatoprost in a separate generation of homozygous FP-knockout mice and wild-type littermate control animals (n = 4 per group). Aqueous humor protein concentrations were measured to establish the state of the blood-aqueous barrier. Tissue, aqueous humor and vitreous concentrations of bimatoprost, latanoprost, and their C-1 free acids were determined by liquid chromatography and tandem mass spectrometry.
A significant reduction in IOP was observed in the bimatoprost-treated eye of wild-type mice at 2 hours, with a mean difference and 95% confidence interval (CI) of the difference in means of -1.33 mm Hg (-0.81 to -1.84). Bimatoprost did not lead to a significant reduction in IOP in either the heterozygous knockout -0.36 mm Hg (-0.82 to +0.09) or homozygous FP-knockout mice 0.25 mm Hg (-0.38 to +0.89). The lack of an IOP response in the FP-knockout mice was not a consequence of blood-aqueous barrier breakdown, as there was no significant difference in aqueous humor protein concentration between treated and fellow eyes. Tissue and aqueous humor concentrations of bimatoprost, latanoprost, and their C-1 free acids indicate that latanoprost, but not bimatoprost, is hydrolyzed in the mouse eye after topical administration.
An intact FP receptor gene is critical to the IOP response to bimatoprost in the mouse eye.
确定比马前列素对前列腺素FP受体敲除小鼠眼压的影响。
在纯合子(FP+/+,n = 9)和杂合子(FP+/−,n = 10)FP敲除小鼠以及野生型C57BL/6小鼠(FP+/+,n = 20)的经治疗和未经治疗的对侧眼中,测量单次1.2微克(4微升)剂量比马前列素引起的眼压反应。在另一代纯合FP敲除小鼠和野生型同窝对照动物(每组n = 4)中,局部应用比马前列素后也进行了系列眼压测量。测量房水蛋白浓度以确定血-房水屏障的状态。通过液相色谱和串联质谱法测定比马前列素、拉坦前列素及其C-1游离酸在组织、房水和玻璃体中的浓度。
野生型小鼠经比马前列素治疗的眼睛在2小时时眼压显著降低,平均差值和差值均值的95%置信区间(CI)为-1.33毫米汞柱(-0.81至-1.84)。比马前列素在杂合敲除小鼠(-0.36毫米汞柱,-0.82至+0.09)或纯合FP敲除小鼠(0.25毫米汞柱,-0.38至+0.89)中均未导致眼压显著降低。FP敲除小鼠缺乏眼压反应并非血-房水屏障破坏的结果,因为治疗眼和对侧眼的房水蛋白浓度无显著差异。比马前列素、拉坦前列素及其C-1游离酸在组织和房水中的浓度表明,局部给药后拉坦前列素在小鼠眼中会水解,但比马前列素不会。
完整的FP受体基因对小鼠眼中比马前列素的眼压反应至关重要。